Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Balx Holdings
AddedMar 20, 2024
UpdatedJun 18, 2026
Balx Holdings

Balx Holdings

Seed

Innovative biotech and healthcare company since 2013.

HQ
Boston, MA, US
Founded
2013
Overview
Compare
Fundraising
Employees

Balx Holdings is a biotechnology and healthcare company founded in 2013 and headquartered in the United States. The company focuses on developing innovative biotech solutions and healthcare services aimed at improving patient outcomes and advancing medical research.

Balx Holdings has made significant strides in the biotech sector, contributing to advancements in medical treatments and technologies. The company's impact is reflected in its growing portfolio of healthcare innovations and its role in enhancing the quality of care within the industry.

Balx Holdings - Similar Companies

Biotech Holdings logo

Biotech Holdings

Healthvest Holdings logo

Healthvest Holdings

Rapalogix Health logo

Rapalogix Health

BLA Technology logo

BLA Technology

Cellarian Holdings logo

Cellarian Holdings

HammiR Holdings logo

HammiR Holdings

BioMedical Technologies Solutions logo

BioMedical Technologies Solutions

Intellimedix logo

Intellimedix

BLR Bio logo

BLR Bio

blrbio.com

Pulmair Medical logo

Pulmair Medical

XRad Therapeutics logo

XRad Therapeutics

Blaire Biomedical logo

Blaire Biomedical

SphynKx Therapeutics logo

SphynKx Therapeutics

BioHealthonomics logo

BioHealthonomics

Carmolex logo

Carmolex

Balx Holdings - Quick Facts

Who are Balx Holdings' competitors?

Companies similar to Balx Holdings include Biotech Holdings, Healthvest Holdings, Rapalogix Health and BLA Technology.

When was Balx Holdings founded?

Balx Holdings was founded in 2013.

Where is Balx Holdings' headquarters located?

Balx Holdings' headquarters is located in Boston, MA, US.

When was Balx Holdings' last funding round?

Balx Holdings' most recent funding round was for $2M (USD) in October 2016.

How much has Balx Holdings raised to-date?

As of Oct 21, 2016, Balx Holdings has raised a total of $9M (USD).

How many employees does Balx Holdings have?

Balx Holdings has 50 employees as of Feb 5, 2024.

Balx Holdings - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biotechnology
  • Healthcare
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research